A. Mittoux

发表

THE SERTINDOLE COHORT PROSPECTIVE (SCOP) STUDY: RATIONALE, DESIGN, AND METHODOLOGY

J. Peuskens, P. Tanghøj, A. Mittoux, 2008, Schizophrenia Research.

Exploring the potential prognostic effect of various country‐specific health service data on all‐cause mortality using data from a large prospective study in schizophrenia

N. Moore, P. Tanghøj, A. Mittoux, 2012, Pharmacoepidemiology and drug safety.

Cardiac effects of sertindole and quetiapine: Analysis of ECGs from a randomized double-blind study in patients with schizophrenia

Jørgen K. Kanters, J. Struijk, E. Toft, 2015, European Neuropsychopharmacology.

A head-to-head comparison of sertindole and risperidone on metabolic parameters

J. Peuskens, M. Hert, A. Mittoux, 2010, Schizophrenia Research.

METABOLIC PARAMETERS IN A SUBSET OF PATIENTS IN THE SCOP STUDY

J. Peuskens, M. Hert, A. Mittoux, 2010, Schizophrenia Research.

The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study

T. Su, J. Kwon, Jae Yeon Hwang, 2012, International clinical psychopharmacology.

PRINCIPAL OUTCOMES OF THE SERTINDOLE COHORT PROSPECTIVE (SCOP) STUDY

J. Peuskens, P. Tanghøj, A. Mittoux, 2010, Schizophrenia Research.

Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone

D. Naber, J. Peuskens, B. Everitt, 2010, European Neuropsychopharmacology.

SUICIDE ATTEMPTS IN THE SCOP STUDY

D. Naber, M. Crocq, P. Tanghøj, 2010, Schizophrenia Research.

Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension

O. Howes, J. Kane, P. Hertel, 2022, Schizophrenia Research.

Course of Recovery of Cognitive Impairment in Patients with Schizophrenia: A Randomised Double-blind Study Comparing Sertindole and Haloperidol

B. Gallhofer, S. Krieger, S. Lis, 2007, Pharmacopsychiatry.

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

C. Lundqvist, L. Carlsen, C. Tassorelli, 2023, Frontiers in Neurology.

Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone

M. De Hert, J. Peuskens, A. Mittoux, 2011, European Archives of Psychiatry and Clinical Neuroscience.

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

B. Everitt, S. Priori, M. Sturkenboom, 2010, Acta psychiatrica Scandinavica.

Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy.

A. Krystal, R. Baker, A. Mittoux, 2020, Journal of affective disorders.

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

S. Priori, M. Sturkenboom, D. Naber, 2010, Acta psychiatrica Scandinavica.

P.2.100 Sertindole is superior to haloperidol in cognitive performance in patients with schizophrenia: A comparative study

B. Gallhofer, S. Krieger, S. Lis, 2003, European Neuropsychopharmacology.